145 related articles for article (PubMed ID: 2997615)
1. Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance.
Rooney CM; Rowe M; Wallace LE; Rickinson AB
Nature; 1985 Oct 17-23; 317(6038):629-31. PubMed ID: 2997615
[TBL] [Abstract][Full Text] [Related]
2. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
Int J Cancer; 1984 Sep; 34(3):339-48. PubMed ID: 6090321
[TBL] [Abstract][Full Text] [Related]
3. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
4. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
Hank JA; Sondel PM
Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
[TBL] [Abstract][Full Text] [Related]
5. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
6. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
Gregory CD; Murray RJ; Edwards CF; Rickinson AB
J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
[TBL] [Abstract][Full Text] [Related]
9. Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.
Rowe DT; Rowe M; Evan GI; Wallace LE; Farrell PJ; Rickinson AB
EMBO J; 1986 Oct; 5(10):2599-607. PubMed ID: 3023050
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
Rowe M; Rooney CM; Edwards CF; Lenoir GM; Rickinson AB
Int J Cancer; 1986 Mar; 37(3):367-73. PubMed ID: 3005176
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of cytotoxic responses by Burkitt's lymphoma (BL)-cell lines: relationship to the BL-cell surface phenotype.
Rooney CM; Edwards CF; Lenoir GM; Rupani H; Rickinson AB
Cell Immunol; 1986 Oct; 102(1):99-112. PubMed ID: 3026651
[TBL] [Abstract][Full Text] [Related]
12. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
[TBL] [Abstract][Full Text] [Related]
13. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
Rowe M; Rooney CM; Rickinson AB; Lenoir GM; Rupani H; Moss DJ; Stein H; Epstein MA
Int J Cancer; 1985 Apr; 35(4):435-41. PubMed ID: 2985508
[TBL] [Abstract][Full Text] [Related]
14. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
Rowe M; Hildreth JE; Rickinson AB; Epstein MA
Int J Cancer; 1982 Apr; 29(4):373-81. PubMed ID: 6282762
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
17. Viruses and cancer risks: outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host.
Rickinson AB; Gregory CD; Young LS
Med Oncol Tumor Pharmacother; 1987; 4(3-4):177-86. PubMed ID: 2831439
[TBL] [Abstract][Full Text] [Related]
18. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
[TBL] [Abstract][Full Text] [Related]
19. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
Masucci MG; Klein E
Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
[TBL] [Abstract][Full Text] [Related]
20. A new Epstein-Barr virus negative Burkitt's lymphoma derived cell-line. I. Analysis of cell surface markers and abnormal expression of HLA antigens.
Kalil J; Fellous M; Tanigaki N; Rosa F; Pagniez C; Herzog C; Dastot H; Lenoir G
Tissue Antigens; 1982 Jul; 20(1):47-62. PubMed ID: 6289490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]